AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15135698 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved exercise HR
Number of subjects: 680
Study 15135698 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved HR
Number of subjects: 680
Study 11322197 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal liquid meal
Number of subjects: 35
Study 11322197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 9142342 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical release
Number of subjects: 2
Study 9142342 — intervention group
Group type: COMPARATOR
Intervention: Long-term hemodialysis
Number of subjects: 2
Study 9142342 — intervention group
Group type: COMPARATOR
Intervention: Idiopathic carpal tunnel syndrome
Number of subjects: 2
Study 8203766 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 (320 mg per day for four weeks)
Number of subjects: 20
Study 8203766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2954005 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha-2C
Number of subjects: 102
Study 2954005 — intervention group
Group type: COMPARATOR
Intervention: IFN alpha-2C plus medroxyprogesteroneacetate
Number of subjects: 102
Study 29633328 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training using the Otago Exercise Programme
Number of subjects: 728
Study 29633328 — intervention group
Group type: COMPARATOR
Intervention: Individual training using the Otago Exercise Programme
Number of subjects: 728
Study 28903476 — intervention group
Group type: EXPERIMENTAL
Intervention: AdVEGF‐DΔNΔC gene therapy
Number of subjects: 30
Study 28903476 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study 27442387 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-education
Number of subjects: 64
Study 27442387 — intervention group
Group type: COMPARATOR
Intervention: Control group without psycho-education
Number of subjects: 64
Study 23187147 — intervention group
Group type: EXPERIMENTAL
Intervention: Air puffs + blinking
Number of subjects: 0
Study 23187147 — intervention group
Group type: COMPARATOR
Intervention: Air puffs without instruction to blink
Number of subjects: 0
Study 23187147 — intervention group
Group type: COMPARATOR
Intervention: No air puffs
Number of subjects: 0
Study 21691281 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (ART)
Number of subjects: 100
Study 21691281 — intervention group
Group type: COMPARATOR
Intervention: Observation plus selective salvage radiotherapy (SRT)
Number of subjects: 100
Study 18335068 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 335
Study 18335068 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel
Number of subjects: 335
Study 16551821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia with terminal warm blood cardioplegia (Group B)
Number of subjects: 40
Study 16551821 — intervention group
Group type: COMPARATOR
Intervention: Cold blood cardioplegia (Group A)
Number of subjects: 40
Study 12589843 — intervention group
Group type: EXPERIMENTAL
Intervention: ME inflation for 10 days
Number of subjects: 198
Study 12589843 — intervention group
Group type: EXPERIMENTAL
Intervention: ME inflation and antibiotics (oral Amoxicillin 500 mg 3/day) for 10 days
Number of subjects: 198
Study 12589843 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 198
Study 10752495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft formula (Clcr = ((140 - age) x body weight)/(72 x Scr), x 0.85 for females)
Number of subjects: 38
Study 10752495 — intervention group
Group type: EXPERIMENTAL
Intervention: Six equations and one nomogram
Number of subjects: 38
Study 9113191 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 50 mg x 4 per day dissolved in juice
Number of subjects: 1
Study 9113191 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 1
Study 8272492 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream 5% applied for 15 to 30 minutes
Number of subjects: 13
Study 3476505 — intervention group
Group type: COMPARATOR
Intervention: 150 micrograms/ml sanguinaria and 0.2% zinc chloride (Rinse B)
Number of subjects: 0
Study 3476505 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 micrograms/ml sanguinaria and no zinc chloride (Rinse C)
Number of subjects: 0
Study 3476505 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 micrograms/ml sanguinaria and 0.2% zinc chloride (Rinse D)
Number of subjects: 0
Study 3476505 — intervention group
Group type: COMPARATOR
Intervention: Placebo oral rinse (Rinse A)
Number of subjects: 0
Study 29443994 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherent light control via feedback-based wavefront shaping
Number of subjects: 0
Study 29443994 — intervention group
Group type: EXPERIMENTAL
Intervention: Random quasi-phase-matching (QPM) scheme
Number of subjects: 0
Study 26474111 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuver with V(RM) calculated by integrating the flow-time waveform during a 30-second breath hold at 40 cm H2O airway pressure
Number of subjects: 42
Study 26474111 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuver with low V(RM)
Number of subjects: 42
Study 25002717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 90
Study 25002717 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based usual care (UC)
Number of subjects: 90
Study 25002717 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent patients (≥ 90 minutes per week)
Number of subjects: 90
Study 25002717 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadherent patients (< 90 minutes per week)
Number of subjects: 90
Study 21968596 — intervention group
Group type: EXPERIMENTAL
Intervention: 3T (triple target treatment)
Number of subjects: 158
Study 21968596 — intervention group
Group type: COMPARATOR
Intervention: EMG-BF (electromyography biofeedback)
Number of subjects: 158
Study 21968596 — intervention group
Group type: EXPERIMENTAL
Intervention: 3T
Number of subjects: 158
Study 20555284 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body compression garments (WBCGs)
Number of subjects: 8
Study 18477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 10 mg/ml
Number of subjects: 40
Study 18477086 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine 7.5 mg/ml
Number of subjects: 40
Study 15713943 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg daily)
Number of subjects: 2586
Study 15713943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2586
Study 15713943 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 2586
Study 12066676 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic toothbrush
Number of subjects: 8
Study 12066676 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical toothbrush
Number of subjects: 8
Study 12066676 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 8
Study 9851651 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg/day for 6 months (Group A)
Number of subjects: 110
Study 9851651 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1000 mg/day for 6 months (Group B)
Number of subjects: 110
Study 9851651 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg/day for 6 months followed by 1000 mg/day for 6 months (Group C)
Number of subjects: 110
Study 9851651 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group D) receiving only symptomatic treatment
Number of subjects: 110
Study 9851651 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (all groups)
Number of subjects: 110
Study 7925878 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine sweat-spot test (0.1 of 1% acetylcholine intradermally injected into the dorsum of the feet)
Number of subjects: 35
Study 7925878 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine sweat-spot test
Number of subjects: 35
Study 2529986 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplement (150 micrograms/d for 21 days)
Number of subjects: 38
Study 2529986 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glucose)
Number of subjects: 38
Study 1092531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized isoproterenol
Number of subjects: 14
Study 1092531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6104295 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimazosin (TMZ) treatment for up to 52 weeks
Number of subjects: 22
Study 6104295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 28278597 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital measurement feedback system (MFS) and brief consultation supports
Number of subjects: 14
Study 28278597 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 28278597 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital measurement feedback system (MFS)
Number of subjects: 14
Study 28651590 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal corneal incision
Number of subjects: 100
Study 28651590 — intervention group
Group type: COMPARATOR
Intervention: Superior corneal incision
Number of subjects: 100
Study 26786567 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% C. indicum water extract cosmetic cream
Number of subjects: 0
Study 26786567 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no extract) cosmetic cream
Number of subjects: 0
Study 25180636 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen implant with gentamicin sulphate (Collatamp(®))
Number of subjects: 60
Study 25180636 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 22577263 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus monotherapy
Number of subjects: 68
Study 22577263 — intervention group
Group type: COMPARATOR
Intervention: Emollient-only maintenance
Number of subjects: 68
Study 19535545 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional development in scientifically based reading instruction (35-hour course on phonemic awareness, phonics, and fluency; coaching for one year)
Number of subjects: 47
Study 19535545 — intervention group
Group type: COMPARATOR
Intervention: Control group (no professional development)
Number of subjects: 47
Study 17633971 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg zoledronic acid annually
Number of subjects: 7765
Study 17633971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7765
Study 14737746 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-microg pramlintide injected at 0 min
Number of subjects: 19
Study 14737746 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-microg pramlintide injected at -15, +15, and +30 min
Number of subjects: 19
Study 14737746 — intervention group
Group type: COMPARATOR
Intervention: Placebo injected at -15 min
Number of subjects: 19
Study 11786572 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (lenograstim) 5 microg/kg/d from day 7 until ANC > or = 500/microL sustained over 48 hours after two induction courses.
Number of subjects: 148
Study 11786572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G-CSF).
Number of subjects: 148
Study 9885888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP)
Number of subjects: 18
Study 9885888 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidim plus gentamicin (CAZ/GM)
Number of subjects: 18
Study 8016006 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 11
Study 8016006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2656769 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% SnF2
Number of subjects: 61
Study 2656769 — intervention group
Group type: COMPARATOR
Intervention: 0.22% NaF
Number of subjects: 61
Study 2656769 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 61
Study 30927000 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthful Plant-Based Diet Index (hPDI)
Number of subjects: 831
Study 30927000 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthful Plant-Based Diet Index (uPDI)
Number of subjects: 831
Study 28384675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 1767
Study 28384675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg
Number of subjects: 1767
Study 28384675 — intervention group
Group type: COMPARATOR
Intervention: Sham/Laser
Number of subjects: 1767
Study 26138423 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive‐noninvasive sequential mechanical ventilation (MV)
Number of subjects: 91
Study 26138423 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (MV)
Number of subjects: 91
Study 23598734 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anesthesia maintained with isoflurane
Number of subjects: 30
Study 23598734 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol
Number of subjects: 30
Study 21225563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert retained for 12 to 24 hours
Number of subjects: 431
Study 19192028 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut meal
Number of subjects: 13
Study 19192028 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond meal
Number of subjects: 13
Study 19192028 — intervention group
Group type: COMPARATOR
Intervention: Control meal (smoothies)
Number of subjects: 13
Study 15896827 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan 80 mg/day for 8 weeks
Number of subjects: 53
Study 14998786 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine boluses (1-60 mg/kg) injected intravenously at 29-min intervals for 120 min
Number of subjects: 10
Study 14998786 — intervention group
Group type: COMPARATOR
Intervention: Basal state (no intervention)
Number of subjects: 10
Study 11156653 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions for IBS (specific interventions not detailed in the abstract)
Number of subjects: 0
Study 11156653 — intervention group
Group type: EXPERIMENTAL
Intervention: Future trials should include well-defined outcome measures and quality of life measures.
Number of subjects: 0
Study 11156653 — intervention group
Group type: EXPERIMENTAL
Intervention: Future trials should be double blinded and placebo controlled.
Number of subjects: 0
Study 9629649 — intervention group
Group type: EXPERIMENTAL
Intervention: Proschan and Hunsberger method
Number of subjects: 0
Study 9629649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bauer and Kohne method
Number of subjects: 0
Study 7977853 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic hypoglycemia (H; 2.5 mmol/l)
Number of subjects: 0
Study 7977853 — intervention group
Group type: COMPARATOR
Intervention: Hyperinsulinemic euglycemia (E; 4.5 mmol/l)
Number of subjects: 0
Study 7977853 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (P; saline)
Number of subjects: 0
Study 2531510 — intervention group
Group type: EXPERIMENTAL
Intervention: ISDN (standard release formulation) 40 mg administered 6 times daily (240 mg total)
Number of subjects: 0
Study 2531510 — intervention group
Group type: EXPERIMENTAL
Intervention: ISDN (40 mg) administered 4 times daily
Number of subjects: 0
Study 2531510 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of glycerol trinitrate (3 mg/h)
Number of subjects: 0
Study 2531510 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ISDN (standard release formulation) administered 4-6 times daily
Number of subjects: 0
Study 2531510 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate therapy providing constant doses over time (e.g. I.V. nitroglycerin)
Number of subjects: 0
Study 1119423 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 8
Study 1119423 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 8
Study 1119423 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 8
Study 1119423 — intervention group
Group type: COMPARATOR
Intervention: Control (Glucose)
Number of subjects: 8
Study 31323455 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 financial stressor
Number of subjects: 22048
Study 31323455 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 financial stressors
Number of subjects: 22048
Study 31323455 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 or more financial stressors
Number of subjects: 22048
Study 27939227 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/day
Number of subjects: 215
Study 26186450 — intervention group
Group type: EXPERIMENTAL
Intervention: S. frutescens 1,200 mg twice daily
Number of subjects: 107
Study 26186450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 23385606 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageless computer-assisted surgery (CAS)
Number of subjects: 75
Study 23385606 — intervention group
Group type: COMPARATOR
Intervention: Conventional implantation
Number of subjects: 75
Study 21504887 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling sessions for mothers (1 face-to-face, 2 by telephone) and fathers (3 by telephone), educational pamphlet, smoke-free home sticker
Number of subjects: 130
Study 21504887 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling sessions for mothers and fathers
Number of subjects: 130
Study 21504887 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 19897434 — intervention group
Group type: EXPERIMENTAL
Intervention: TEFI (Transient Expiratory Flow Interruptions) using a device with an inspiratory line and a valve interrupting flow at 4 Hz
Number of subjects: 30
Study 19897434 — intervention group
Group type: COMPARATOR
Intervention: Control group with the valve kept open
Number of subjects: 30
Study 17658455 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 0.5%
Number of subjects: 7
Study 17658455 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 1%
Number of subjects: 7
Study 17658455 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 2%
Number of subjects: 7
Study 17658455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 15193203 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned vaginal birth
Number of subjects: 64
Study 15193203 — intervention group
Group type: COMPARATOR
Intervention: Planned Caesarean delivery
Number of subjects: 64
Study 15193203 — intervention group
Group type: EXPERIMENTAL
Intervention: Not sure about participation
Number of subjects: 64
Study 11675816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 44
Study 11675816 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 44
Study 9286131 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary crisis intervention for psychiatric patients referred to the emergency department.
Number of subjects: 0
Study 9286131 — intervention group
Group type: COMPARATOR
Intervention: Short-term psychiatric inpatient treatment in another hospital.
Number of subjects: 0
Study 8329826 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose GHRH(1-29)-NH2 (LD group; n = 15) at 30 micrograms/kg/day s.c. in three daily doses
Number of subjects: 43
Study 8329826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GHRH(1-29)-NH2 (HD group; n = 12) at 60 micrograms/kg/day s.c. in three daily doses
Number of subjects: 43
Study 8329826 — intervention group
Group type: COMPARATOR
Intervention: Growth hormone (GH group; n = 16) at 0.1 IU/kg/day s.c. once daily
Number of subjects: 43
Study 3329851 — intervention group
Group type: EXPERIMENTAL
Intervention: FD group (154 micrograms fentanyl plus 5.5 mg droperidol i.v.)
Number of subjects: 87
Study 3329851 — intervention group
Group type: COMPARATOR
Intervention: FV group (127 micrograms fentanyl plus 6.7 mg Valium)
Number of subjects: 87
Study 31626000 — intervention group
Group type: EXPERIMENTAL
Intervention: Education Centered Medical Home (ECMH)
Number of subjects: 329
Study 31626000 — intervention group
Group type: COMPARATOR
Intervention: Mentored Individual Preceptorship (IP)
Number of subjects: 329
Study 29034740 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamiguibi-tang (GGBT)
Number of subjects: 30
Study 29034740 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 30
Study 27644633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (500 mg ginger powder, twice a day for 3 days)
Number of subjects: 150
Study 27644633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 23892521 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated ferric saccharate (MFS)
Number of subjects: 17
Study 23892521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (FS)
Number of subjects: 17
Study 21464158 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 69
Study 21464158 — intervention group
Group type: COMPARATOR
Intervention: sorafenib + interferon‐α (IFN‐α)
Number of subjects: 69
Study 21609911 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride treatment after Epley's maneuver (EM)
Number of subjects: 90
Study 21609911 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment with betahistine after EM)
Number of subjects: 90
Study 18313995 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir phosphate preparation 1
Number of subjects: 24
Study 18313995 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir phosphate preparation 2
Number of subjects: 24
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooked Russet potatoes
Number of subjects: 22
Study 15800557 — intervention group
Group type: COMPARATOR
Intervention: Day-cooked Russet potatoes
Number of subjects: 22
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled white potatoes
Number of subjects: 22
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Various potato varieties and cooking methods
Number of subjects: 22
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant mashed potatoes
Number of subjects: 22
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled red potatoes
Number of subjects: 22
Study 15800557 — intervention group
Group type: EXPERIMENTAL
Intervention: Roasted California white potatoes
Number of subjects: 22